Pibao Li

2.3k total citations · 1 hit paper
16 papers, 1.6k citations indexed

About

Pibao Li is a scholar working on Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Pibao Li has authored 16 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Pibao Li's work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (4 papers) and COVID-19 diagnosis using AI (3 papers). Pibao Li is often cited by papers focused on MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (4 papers) and COVID-19 diagnosis using AI (3 papers). Pibao Li collaborates with scholars based in China, Spain and New Zealand. Pibao Li's co-authors include Jun‐Hong Yan, Qinyong Hu, Lei Tu, Chao Hu, Lei Pan, Mi Mu, Pengcheng Yang, Jing Wang, Tianzhi Li and Yu Sun and has published in prestigious journals such as PLoS ONE, IEEE Access and The American Journal of Gastroenterology.

In The Last Decade

Pibao Li

16 papers receiving 1.5k citations

Hit Papers

Clinical Characteristics of COVID-19 Patients With Digest... 2020 2026 2022 2024 2020 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study
    2020 1.2k citations Lei Pan, Mi Mu et al. The American Journal of Gastroenterology profile →

Peers

Pibao Li
Jiawei Zou China
Yan Xiong China
Zili Zhang China
Zhao Wu China
Gaurav Aggarwal United States
Hui Long China
Daniela Tomasoni Italy
Jiawei Zou China
Pibao Li
Citations per year, relative to Pibao Li Pibao Li (= 1×) peers Jiawei Zou

Countries citing papers authored by Pibao Li

Since Specialization
Citations

This map shows the geographic impact of Pibao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pibao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pibao Li more than expected).

Fields of papers citing papers by Pibao Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pibao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pibao Li. The network helps show where Pibao Li may publish in the future.

Co-authorship network of co-authors of Pibao Li

This figure shows the co-authorship network connecting the top 25 collaborators of Pibao Li. A scholar is included among the top collaborators of Pibao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pibao Li. Pibao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Li, Ranran, Ju Bai, Yufeng Chu, et al.. (2024). GDF15 ameliorates sepsis-induced lung injury via AMPK-mediated inhibition of glycolysis in alveolar macrophage. Respiratory Research. 25(1). 9 indexed citations
2.
Ding, Ning, et al.. (2022). The ROCK-ezrin signaling pathway mediates LPS-induced cytokine production in pulmonary alveolar epithelial cells. Cell Communication and Signaling. 20(1). 65–65. 12 indexed citations
3.
Li, Pibao, et al.. (2022). Evaluating the effectiveness of drug and therapeutics committees (DTCs) in controlling irrational drug use: A retrospective analysis. Journal of Clinical Pharmacy and Therapeutics. 47(7). 995–1001. 2 indexed citations
4.
Liu, Xiaojing, Na Niu, Pibao Li, et al.. (2021). LncRNA OGFRP1 acts as an oncogene in NSCLC via miR-4640-5p/eIF5A axis. Cancer Cell International. 21(1). 425–425. 18 indexed citations
5.
Yang, Jing, et al.. (2021). Pharmacist‐led, prescription intervention system‐assisted feedback to reduce prescribing errors: A retrospective study. Journal of Clinical Pharmacy and Therapeutics. 46(6). 1606–1612. 6 indexed citations
6.
Liu, Na, et al.. (2020). MiR-297 alleviates LPS-induced A549 cell and mice lung injury via targeting cyclin dependent kinase 8. International Immunopharmacology. 80. 106197–106197. 20 indexed citations
7.
Li, Pibao, et al.. (2020). MiR-30a-5p ameliorates LPS-induced inflammatory injury in human A549 cells and mice via targeting RUNX2. Innate Immunity. 27(1). 41–49. 14 indexed citations
8.
Pan, Lei, Mi Mu, Pengcheng Yang, et al.. (2020). Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study. The American Journal of Gastroenterology. 115(5). 766–773. 1234 indexed citations breakdown →
9.
Pang, Shanchen, Shuo Wang, Alfonso Rodríguez‐Patón, Pibao Li, & Xun Wang. (2019). An artificial intelligent diagnostic system on mobile Android terminals for cholelithiasis by lightweight convolutional neural network. PLoS ONE. 14(9). e0221720–e0221720. 23 indexed citations
10.
Pang, Shanchen, et al.. (2019). A novel YOLOv3-arch model for identifying cholelithiasis and classifying gallstones on CT images. PLoS ONE. 14(6). e0217647–e0217647. 62 indexed citations
11.
Li, Pibao, et al.. (2019). MiR-150 attenuates LPS-induced acute lung injury via targeting AKT3. International Immunopharmacology. 75. 105794–105794. 53 indexed citations
12.
Jia, Haiyan, et al.. (2019). miR-297 Protects Human Umbilical Vein Endothelial Cells against LPS-Induced Inflammatory Response and Apoptosis. Cellular Physiology and Biochemistry. 52(4). 696–707. 21 indexed citations
13.
Song, Tao, Fan Meng, Alfonso Rodríguez‐Patón, et al.. (2019). U-Next: A Novel Convolution Neural Network With an Aggregation U-Net Architecture for Gallstone Segmentation in CT Images. IEEE Access. 7. 166823–166832. 32 indexed citations
14.
15.
Jia, Haiyan, et al.. (2018). miR-136 Inhibits Malignant Progression of Hepatocellular Carcinoma Cells by Targeting Cyclooxygenase 2. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 26(6). 967–976. 13 indexed citations
16.
Li, Pibao, et al.. (2018). Growth suppression of glioma cells using HDAC6 inhibitor, tubacin. Open Medicine. 13(1). 221–226. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiawei Zou Breakdown of academic impact, for papers by Yan Xiong Breakdown of academic impact, for papers by Zili Zhang Breakdown of academic impact, for papers by Zhao Wu Breakdown of academic impact, for papers by Gaurav Aggarwal Breakdown of academic impact, for papers by Hui Long Breakdown of academic impact, for papers by Daniela Tomasoni
Rankless by CCL
2026